CompoAtlas

Vivaprime Women 50+

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sélénium

Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH)

50 mcgNot calculated
Vitamine E

Source : d-a-tocopheryl acid succinate

Potency : 50 UI

33.5 mg ATNot calculated
bêta-carotène

Source : Bêta-carotène tout trans

Potency : 875 UI

525 mcgNot calculated
Biotine

Source : Biotine

56.25 mcgNot calculated
Vitamine B12

Source : Méthylcobalamine

18.75 mcgNot calculated
Magnésium

Source : Oxyde de magnésium

16.25 mgNot calculated
Phosphore

Source : Phosphate dicalcique

19.5 mgNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

25 mgNot calculated
Niacine

Source : Acide nicotinique

37.5 mgNot calculated
Cuivre

Source : Produit de chélation de composé cuivrique et de PVH

300 mcgNot calculated
Tagetes erecta

Source : Fleur

Potency : 1.5 mg lutein esters

7.5 mgNot calculated
Tagetes erecta

Source : Fleur

Potency : 0.3 mg zeaxanthin esters

Not specifiedNot calculated
Passiflora incarnata

Source : Herb top extract

Potency : 4 % flavones

7.5 mgNot calculated
Calcium

Source : Phosphate de calcium, dibasique

25.48 mgNot calculated
Zinc

Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH)

3 mgNot calculated
Vitis vinifera

Source : Seed (standardized extract)

Potency : 95 % proanthocyanidins

6.25 mgNot calculated
Lécithine

Source : Huile de soja

6.25 mgNot calculated
Eleutherococcus senticosus

Source : Extrait de racine

Extraction ratio : 4:1

Dry plant equivalent : 30 mg

Potency : 1 % eleutherosides

7.5 mgNot calculated
Potassium

Source : Chlorure de potassium

25 mgNot calculated

Non-medicinal ingredients

Microcrystalline cellulose, gomme de guar, Dioxyde de silicium, propylèneglycol, Stéarate de magnésium, Hydroxypropyl methylcellulose, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
AdultesNot specified4 CompriméNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of vitamin A to help maintain eyesight, skin membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Helps in the development and maintenance of bones and teeth. An antioxidant for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. Helps to produce red blood cells. Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Helps to produce and repair connective tissue. Helps to form red blood cells. Provides support for healthy glucose metabolism.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Mission Vivacare Inc.
NPN or DIN-HM
80035211
Status
Active licence
Licence date
31 August 2012
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80035211

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Passiflora incarnata
    Read the warning, when it applies and the studies cited

    PASSIONFLOWER -PASSIFLORA INCARNATA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).

    Sources cited by Health Canada (2)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002

    Condition of application: Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    Health Canada monograph dated 29 November 2024

  • Lécithine
    Read the warning, when it applies and the studies cited
  • Eleutherococcus senticosus
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    Sources cited by Health Canada (5)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
    • Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Vivaprime Women 50+”, https://compoatlas.com/en/supplements/canada/80035211-vivaprime-women-50, updated 31 August 2012.

Enter to analyse, Shift+Enter for a new line